首頁 > 市場調查報告書 > 製藥

藥物開發開發業務受託機關

市場調查報告書

商品編碼

1568396

CRO（業務藥物開發）服務的全球市場

Global Market for Contract Research Organization (CRO) Services

出版日期: 2024年10月11日 | 出版商:

BCC Research | 英文 169 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

全球CRO（業務藥物開發）服務市場規模預計將從2024年的1,118億美元增至2029年終的1,660億美元，預測期內複合年成長率為8.2%。

臨床試驗產業預計將從 2024 年的 841 億美元成長到 2029年終的1,265 億美元，預測期內複合年成長率為 8.5%。臨床前研究領域預計將從 2024 年的 139 億美元增至 2029年終的205 億美元，複合年成長率為 8.0%。

本報告調查了全球CRO（業務藥物開發）服務市場，並提供了市場概況、市場影響因素和市場機會、法律制度、新興技術和技術發展趨勢以及市場規模趨勢和預測的分析，詳細編制。品類、區域分析、競爭格局、主要企業概況等

細分細分
全球 CRO 服務市場：依功能分類
世界市場規模/預測
臨床試驗
臨床前研究
藥物發現
中心實驗室
全球 CRO 服務市場：按治療領域
世界市場規模/預測
瘤
心臟病
代謝
神經
免疫
其他
全球 CRO 服務市場：依最終用戶分類
世界市場規模/預測
生物製藥公司
學術研究所
地域分佈
全球 CRO 服務市場：按地區
世界市場規模/預測
北美洲
歐洲
亞太地區
其他

第7章競爭訊息

概述
競爭格局
M&A
SWOT分析

第8章 CRO 服務市場的永續性：ESG 視角

ESG：簡介
CRO 服務市場的永續性
ESG觀點
環境影響
社會影響
管治

第9章附錄

調查方法
簡稱
來源
公司簡介
CHARLES RIVER LABORATORIES
FRONTAGE LABS.
ICON PLC
IQVIA INC.
LABORATORY CORPORATION OF AMERICA HOLDINGS
MEDPACE
PAREXEL INTERNATIONAL CORP.
SYNEOS HEALTH
THERMO FISHER SCIENTIFIC INC.
WUXI APPTEC

簡介目錄圖表

Product Code: PHM186C

The global market for contract research organization (CRO) services is expected to grow from $111.8 billion in 2024 and is projected to reach $166.0 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.2% during the forecast period of 2024 to 2029.

The global market for clinical trials functional services of CRO is expected to grow from $84.1 billion in 2024 and is projected to reach $126.5 billion by the end of 2029, at a CAGR of 8.5% during the forecast period of 2024 to 2029.

The global market for preclinical research functional services of CRO is expected to grow from $13.9 billion in 2024 and is projected to reach $20.5 billion by the end of 2029, at a CAGR of 8.0% during the forecast period of 2024 to 2029.

Report Scope

This report analyzes the global contract research organization (CRO) services market and will cover all the major global CRO companies. It provides a comprehensive overview of the clinical trial process, including a detailed description of all the phases and functional services CROs associated with clinical trials; and it details the major therapeutic areas covered by CROs and their broad service offerings.

As part of this analysis, the CRO services market is divided by functional services into the following market segments: clinical trials services, preclinical research, drug discovery and central lab. It is segmented by therapeutic area into the following markets: oncology, cardiology, metabolic, neurology, immunology and other applications (such as CNS, respiratory and genetic diseases). Based on end user, it is segmented into biopharmaceutical companies as well as academic research institutions.

The global CRO services market is also segmented by geography into these regions: North America, Europe, Asia-Pacific, and Rest of the World (RoW). The regional analysis includes a detailed examination of the major countries operating in this market such as the U.S., Germany, the U.K., France, Japan, China and India.

This report analyzes the market trends associated with CRO services using data from 2023, which serves as the base year. Market estimates are provided for 2024, and forecasts of compound annual growth rates are given for the period 2024 through 2029. The report will also highlight the current and future potential of the CRO services market, and will give a detailed analysis of this market's competitive landscape by covering regulatory scenarios, drivers, restraints and opportunities, as well as the market share of key players.

Emerging trends and changing market dynamics within the CRO industry are also analyzed in detail in this report.

This report's goals include:

Analyzing technologies and applications.
Analyzing global market size and segmentation.
Understanding market constraints and drivers.
Providing detailed market forecasts through 2029.
Assessing market shares, competitiveness and industry structure.
Identifying potential long-term impacts on the CRO services market.

Report Includes

86 data tables and 33 additional tables
An overview of the current and future global market for contract research organization (CRO) services
Analyses of global market trends, with market revenue data for 2021-2023, estimates for 2024, forecasts for 2029 and projected CAGRs through 2029
Estimates of the market size and revenue forecasts for the global CRO market, with market share analysis based on functional services, therapeutic area, end user, and region
Information on CDISC standards, and regulations on sponsor activities; discussion of the impact of FDA regulations on the pharmaceutical industry and the potential long-term impacts of CROs on the drug discovery technologies market
Discussions of the market dynamics, opportunities and challenges, as well as emerging technologies
Overview of the sustainability trends and ESG developments in the industry, with emphasis on the ESG practices followed by leading companies, their ESG ratings, and consumer attitudes
Competitive intelligence, including companies' market shares, recent M&A activity and venture funding
Profiles of the leading companies, including IQVIA Inc., PPD Inc., ICON plc., Charles River Laboratories International Inc., and LabCorp.

Chapter 1 Executive Summary

Market Outlook
Scope of the Report
Market Summary

Chapter 2 Market Overview

Overview
Porter's Five Forces Analysis
Bargaining Power of Buyers
Bargaining Power of Suppliers
Potential for New Entrants
Threat of Substitutes
Competitiveness in the Industry

Chapter 3 Market Dynamics

Market Dynamics
Market Drivers
Increasing Adoption of AI in CROs
R&D Investment in Biotech & Pharma Companies
Rising Prevalence of Chronic and Immunological Diseases Globally
CROs Add Efficiency
Market Restraints
Challenges in CRO Outsourcing
Shortage of Skilled Professionals
Market Opportunities
Inorganic Strategies

Chapter 4 Regulatory Landscape

FDA Regulation and Impact
Regulations on Sponsor Activities
CDISC Standards
BIMO Program
European Standards

Chapter 5 Emerging Technologies

Overview
Computer-Based Techniques
Decentralized Clinical Trials
Advanced Analytics and Simulation

Chapter 6 Market Segmentation Analysis

Segmentation Breakdown
Global Market CRO Services by Functional Services
Global Market Size and Forecast
Clinical Trials
Preclinical Research
Drug Discovery
Central Lab
Global Market for CRO Services by Therapeutic Area
Global Market Size and Forecast
Oncology
Cardiology
Metabolic
Neurology
Immunology
Other Applications
Global Market for CRO Services, by End User
Global Market Size and Forecast
Biopharmaceutical Companies
Academic Research Institutions
Geographic Breakdown
Global Market for CRO Services by Region
Global Market Size and Forecast
North America
Europe
Asia-Pacific
Rest of World

Chapter 7 Competitive Intelligence

Overview
Competitive Landscape
Mergers and Acquisitions
SWOT Analysis
Strengths of the Global Market for CRO Services
Weaknesses of the Global Market for CRO Services
Opportunities in the Global Market for CRO Services
Threats to the Global Market for CRO Services

Chapter 8 Sustainability in CRO Services Market: An ESG Perspective

Introduction to ESG
Sustainability in the CRO Services Market
ESG Perspective
Environmental Impact
Social Impact
Governance

Chapter 9 Appendix

Methodology
Abbreviations
Sources
Company Profiles
CHARLES RIVER LABORATORIES
FRONTAGE LABS.
ICON PLC
IQVIA INC.
LABORATORY CORPORATION OF AMERICA HOLDINGS
MEDPACE
PAREXEL INTERNATIONAL CORP.
SYNEOS HEALTH
THERMO FISHER SCIENTIFIC INC.
WUXI APPTEC

簡介目錄圖表

List of Tables

Summary Table : Global Market for CRO Services, by Functional Services, Through 2029
Table 1 : Summary of Porter's Five Forces Analysis: CRO Services Market
Table 2 : Global Market for CRO Services, by Functional Services, Through 2029
Table 3 : Clinical Trail Illustration
Table 4 : Clinical Trial Phase Description
Table 5 : Global Market for CRO Services in Clinical Trials, by Region, Through 2029
Table 6 : Global Market for CRO Services in Preclinical Research, by Region, Through 2029
Table 7 : Global Market for CRO Services in Drug Discovery, by Region, Through 2029
Table 8 : Global Market for CRO Services in Central Laboratories, by Region, Through 2029
Table 9 : Global Market for CRO Services, by Therapeutic Area, Through 2029
Table 10 : Global Market for CRO Services in Oncology, by Region, Through 2029
Table 11 : Global Market for CRO Services in Cardiology, by Region, Through 2029
Table 12 : Global Market for CRO Services in Metabolic Diseases, by Region, Through 2029
Table 13 : Global Market for CRO Services in Neurology, by Region, Through 2029
Table 14 : Global Market for CRO Services in Immunological Disorders, by Region, Through 2029
Table 15 : Global Market for CRO Services in Other Therapeutic Areas, by Region, Through 2029
Table 16 : Global Market for CRO Services, by End User, Through 2029
Table 17 : Global Market for CRO Services in Biopharmaceutical Companies, by Region, Through 2029
Table 18 : Global Market for CRO Services in Academic Research Institutions, by Region, Through 2029
Table 19 : Global Market for CRO Services, by Region, Through 2029
Table 20 : Diabetes Estimates in North America, by Country, 2000-2045
Table 21 : North American Market for CRO Services, by Functional Services, Through 2029
Table 22 : North American Market for CRO Services, by Therapeutic Area, Through 2029
Table 23 : North American Market for CRO Services, by End User, Through 2029
Table 24 : North American Market for CRO Services, by Country, Through 2029
Table 25 : U.S. Market for CRO Services, by Functional Services, Through 2029
Table 26 : U.S. Market for CRO Services, by Therapeutic Area, Through 2029
Table 27 : U.S. Market for CRO Services, by End User, Through 2029
Table 28 : Canadian Market for CRO Services, by Functional Services, Through 2029
Table 29 : Canadian Market for CRO Services, by Therapeutic Area, Through 2029
Table 30 : Canadian Market for CRO Services, by End User, Through 2029
Table 31 : Mexican Market for CRO Services, by Functional Services, Through 2029
Table 32 : Mexican Market for CRO Services, by Therapeutic Area, Through 2029
Table 33 : Mexican Market for CRO Services, by End User, Through 2029
Table 34 : Diabetes Estimates for the Top 10 European Countries, 2000-2045
Table 35 : European Market for CRO Services, by Functional Services, Through 2029
Table 36 : European Market for CRO Services, by Therapeutic Area, Through 2029
Table 37 : European Market for CRO Services, by End User, Through 2029
Table 38 : European Market for CRO Services, by Country, Through 2029
Table 39 : German Market for CRO Services, by Functional Services, Through 2029
Table 40 : German Market for CRO Services, by Therapeutic Area, Through 2029
Table 41 : German Market for CRO Services, by End User, Through 2029
Table 42 : U.K. Market for CRO Services, by Functional Services, Through 2029
Table 43 : U.K. Market for CRO Services, by Therapeutic Area, Through 2029
Table 44 : U.K. Market for CRO Services, by End User, Through 2029
Table 45 : French Market for CRO Services, by Functional Services, Through 2029
Table 46 : French Market for CRO Services, by Therapeutic Area, Through 2029
Table 47 : French Market for CRO Services, by End User, Through 2029
Table 48 : Rest of the European Market for CRO Services, by Functional Services, Through 2029
Table 49 : Rest of the European Market for CRO Services, by Therapeutic Area, Through 2029
Table 50 : Rest of the European Market for CRO Services, by End User, Through 2029
Table 51 : Diabetes Estimates for the Asia-Pacific Region, by Country, 2000-2045
Table 52 : Asia-Pacific Market for CRO Services, by Functional Services, Through 2029
Table 53 : Asia-Pacific Market for CRO Services, by Therapeutic Area, Through 2029
Table 54 : Asia-Pacific Market for CRO Services, by End User, Through 2029
Table 55 : Asia-Pacific Market for CRO Services, by Country, Through 2029
Table 56 : Chinese Market for CRO Services, by Functional Services, Through 2029
Table 57 : Chinese Market for CRO Services, by Therapeutic Area, Through 2029
Table 58 : Chinese Market for CRO Services, by End User, Through 2029
Table 59 : Japanese Market for CRO Services, by Functional Services, Through 2029
Table 60 : Japanese Market for CRO Services, by Therapeutic Area, Through 2029
Table 61 : Japanese Market for CRO Services, by End User, Through 2029
Table 62 : Indian Market for CRO Services, by Functional Services, Through 2029
Table 63 : Indian Market for CRO Services, by Therapeutic Area, Through 2029
Table 64 : Indian Market for CRO Services, by End User, Through 2029
Table 65 : Rest of Asia-Pacific Market for CRO Services, by Functional Services, Through 2029
Table 66 : Rest of Asia-Pacific Market for CRO Services, by Therapeutic Area, Through 2029
Table 67 : Rest of Asia-Pacific Market for CRO Services, by End User, Through 2029
Table 68 : Rest of the World Market for CRO Services, by Functional Services, Through 2029
Table 69 : Rest of the World Market for CRO Services, by Therapeutic Area, Through 2029
Table 70 : Rest of the World Market for CRO Services, by End User, Through 2029
Table 71 : Rest of the World Market for CRO Services, by Sub-Region, Through 2029
Table 72 : South American Market for CRO Services, by Functional Services, Through 2029
Table 73 : South American Market for CRO Services, by Therapeutic Area, Through 2029
Table 74 : South American Market for CRO Services, by End User, Through 2029
Table 75 : Middle Eastern and African Market for CRO Services, by Functional Services, Through 2029
Table 76 : Middle Eastern and African Market for CRO Services, by Therapeutic Area, Through 2029
Table 77 : Middle Eastern and African Market for CRO Services, by End User, Through 2029
Table 78 : Service Offerings, Major CROs
Table 79 : Pharmaceutical and CRO Partnership Alliances
Table 80 : Recent M&As in CROs Services Market, 2020-2024
Table 81 : Key ESG Metrics in the CRO Services Market
Table 82 : ESG Rankings for CRO Services
Table 83 : Abbreviations Used in this Report
Table 84 : Report Sources
Table 85 : Charles River Laboratories: Company Snapshot
Table 86 : Charles River Laboratories: Financial Performance, FY 2022 and 2023
Table 87 : Charles River Laboratories: Service Portfolio
Table 88 : Charles River Laboratories: News/Key Developments, 2021-2024
Table 89 : Frontage Labs.: Company Snapshot
Table 90 : Frontage Labs.: Financial Performance, FY 2022 and 2023
Table 91 : Frontage Labs.: Product Portfolio
Table 92 : Frontage Labs.: News/Key Development, 2022-2024
Table 93 : ICON plc: Company Snapshot
Table 94 : ICON plc: Financial Performance, FY 2022 and 2023
Table 95 : ICON plc: Product Portfolio
Table 96 : ICON plc: News/Key Development, 2020-2023
Table 97 : IQVIA Inc.: Company Snapshot
Table 98 : IQVIA Inc.: Financial Performance, FY 2022 and 2023
Table 99 : IQVIA Inc.: Service Portfolio
Table 100 : IQVIA Inc.: News/Key Developments, 2024
Table 101 : Laboratory Corporation of America Holdings: Company Snapshot
Table 102 : Laboratory Corporation of America Holdings: Financial Performance, FY 2022 and 2023
Table 103 : Laboratory Corporation of America Holdings: Service Portfolio
Table 104 : Laboratory Corporation of America Holdings: News/Key Developments, 2024
Table 105 : Medpace: Company Snapshot
Table 106 : Medpace: Financial Performance, FY 2022 and 2023
Table 107 : Medpace: Service Portfolio
Table 108 : Parexel International Corp.: Company Snapshot
Table 109 : Parexel International Corp.: Service Portfolio
Table 110 : Syneos Health: Company Snapshot
Table 111 : Syneos Health: Service Portfolio
Table 112 : Thermo Fisher Scientific Inc.: Company Snapshot
Table 113 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2022 and 2023
Table 114 : Thermo Fisher Scientific Inc.: Product Portfolio
Table 115 : Thermo Fisher Scientific Inc.: News/Key Developments, 2023
Table 116 : WuXi AppTec: Company Snapshot
Table 117 : WuXi AppTec: Financial Performance, FY 2022 and 2023
Table 118 : WuXi AppTec: Service Portfolio

List of Figures

Summary Figure : Global Market for CRO Services, by Functional Services, 2021-2029
Figure 1 : CRO Services: Market Dynamics
Figure 2 : Global Market Shares of CRO Services, by Functional Services, 2023
Figure 3 : Overall Phase Transition Success Rates in Biologic Drug Development
Figure 4 : Phase II Transition Success Rates, by Disease Area, 2021
Figure 5 : Phase III Transition Success Rates, by Disease Area, 2021
Figure 6 : Global Market Shares of CRO Services Throughout the Clinical Trial Process, by Phase, 2023
Figure 7 : Phase IV Transition Success Rates, by Disease Area, 2021
Figure 8 : Global Market for CRO Services in Clinical Trials, by Region, 2021-2029
Figure 9 : Global Market for CRO Services in Preclinical Research, by Region, 2021-2029
Figure 10 : CRO Services Related to Drug Discovery
Figure 11 : Global Market for CRO Services in Drug Discovery, by Region, 2021-2029
Figure 12 : Global Market for CRO Services in Central Laboratories, by Region, 2021-2029
Figure 13 : Global Market Shares of CRO Services, by Therapeutic Area, 2023
Figure 14 : Global Market Shares of CRO Services in Oncology, by Region, 2023
Figure 15 : Global Market Shares of CRO Services in Cardiology, by Region, 2023
Figure 16 : Global Market Shares of CRO Services in Metabolic Diseases, by Region, 2023
Figure 17 : Global Market Shares of CRO Services in Neurology, by Region, 2023
Figure 18 : Global Market Shares of CRO Services in Immunological Disorders, by Region, 2023
Figure 19 : Global Market Shares of CRO Services in Other Therapeutic Areas, by Region, 2023
Figure 20 : Global Market Shares of CRO Services, by End User, 2023
Figure 21 : Global Market Shares of CRO Services in Biopharmaceutical companies, by Region, 2023
Figure 22 : Global Market Shares of CRO Services in Academic Research Institutions, by Region, 2023
Figure 23 : Global Market for CRO Services, by Region, 2021-2029
Figure 24 : North American Market for CRO Services, by Functional Services, 2021-2029
Figure 25 : North American Market for CRO Services, by Therapeutic Area, 2021-2029
Figure 26 : North American Market for CRO Services, by End User, 2021-2029
Figure 27 : North American Market Shares of CRO Services, by Country, 2023
Figure 28 : U.S. Market for CRO Services, by Functional Services, 2021-2029
Figure 29 : U.S. Market for CRO Services, by Therapeutic Area, 2021-2029
Figure 30 : U.S. Market for CRO Services, by End User, 2021-2029
Figure 31 : Canadian Market for CRO Services, by Functional Services, 2021-2029
Figure 32 : Canadian Market for CRO Services, by Therapeutic Area, 2021-2029
Figure 33 : Canadian Market for CRO Services, by End User, 2021-2029
Figure 34 : Mexican Market for CRO Services, by Functional Services, 2021-2029
Figure 35 : Mexican Market for CRO Services, by Therapeutic Area, 2021-2029
Figure 36 : Mexican Market for CRO Services, by End User, 2021-2029
Figure 37 : European Market for CRO Services, by Functional Services, 2021-2029
Figure 38 : European Market for CRO Services, by Therapeutic Area, 2021-2029
Figure 39 : European Market for CRO Services, by End User, 2021-2029
Figure 40 : European Market Shares of CRO Services, by Country, 2023
Figure 41 : German Market for CRO Services, by Functional Services, 2021-2029
Figure 42 : German Market for CRO Services, by Therapeutic Area, 2021-2029
Figure 43 : German Market for CRO Services, by End User, 2021-2029
Figure 44 : U.K. Market for CRO Services, by Functional Services, 2021-2029
Figure 45 : U.K. Market for CRO Services, by Therapeutic Area, 2021-2029
Figure 46 : U.K. Market for CRO Services, by End User, 2021-2029
Figure 47 : French Market for CRO Services, by Functional Services, 2021-2029
Figure 48 : French Market for CRO Services, by Therapeutic Area, 2021-2029
Figure 49 : French Market for CRO Services, by End User, 2021-2029
Figure 50 : Rest of the European Market for CRO Services, by Functional Services, 2021-2029
Figure 51 : Rest of the European Market for CRO Services, by Therapeutic Area, 2021-2029
Figure 52 : Rest of the European Market for CRO Services, by End User, 2021-2029
Figure 53 : Asia-Pacific Market for CRO Services, by Functional Services, 2021-2029
Figure 54 : Asia-Pacific Market for CRO Services, by Therapeutic Area, 2021-2029
Figure 55 : Asia-Pacific Market for CRO Services, by End User, 2021-2029
Figure 56 : Asia-Pacific Market Shares of CRO Services, by Country, 2023
Figure 57 : Chinese Market for CRO Services, by Functional Services, 2021-2029
Figure 58 : Chinese Market for CRO Services, by Therapeutic Area, 2021-2029
Figure 59 : Chinese Market for CRO Services, by End User, 2021-2029
Figure 60 : Japanese Market for CRO Services, by Functional Services, 2021-2029
Figure 61 : Japanese Market for CRO Services, by Therapeutic Area, 2021-2029
Figure 62 : Japanese Market for CRO Services, by End User, 2021-2029
Figure 63 : Indian Market for CRO Services, by Functional Services, 2021-2029
Figure 64 : Indian Market for CRO Services, by Therapeutic Area, 2021-2029
Figure 65 : Indian Market for CRO Services, by End User, 2021-2029
Figure 66 : Rest of Asia-Pacific Market for CRO Services, by Functional Services, 2021-2029
Figure 67 : Rest of Asia-Pacific Market for CRO Services, by Therapeutic Area, 2021-2029
Figure 68 : Rest of Asia-Pacific Market for CRO Services, by End User, 2021-2029
Figure 69 : Rest of the World Market for CRO Services, by Functional Services, 2021-2029
Figure 70 : Rest of the World Market for CRO Services, by Therapeutic Area, 2021-2029
Figure 71 : Rest of the World Market for CRO Services, by End User, 2021-2029
Figure 72 : Rest of the World Market Shares of CRO Services, by Sub-Region, 2023
Figure 73 : South American Market for CRO Services, by Functional Services, 2021-2029
Figure 74 : South American Market for CRO Services, by Therapeutic Area, 2021-2029
Figure 75 : South American Market for CRO Services, by End User, 2021-2029
Figure 76 : Middle Eastern and African Market for CRO Services, by Functional Services, 2021-2029
Figure 77 : Middle Eastern and African Market for CRO Services, by Therapeutic Area, 2021-2029
Figure 78 : Middle Eastern and African Market for CRO Services, by End User, 2021-2029
Figure 79 : Global Market Shares of CRO Services, by Company, 2020
Figure 80 : SWOT Analysis of the CRO Services Market
Figure 81 : Pillars of ESG
Figure 82 : Advantages of ESG for CRO Services Companies
Figure 83 : Charles River Laboratories: Revenue Share, by Business Unit, FY 2023
Figure 84 : Charles River Laboratories: Revenue Share, by Country/Region, FY 2023
Figure 85 : Frontage Labs.: Revenue Share, by Business Unit, FY 2023
Figure 86 : Frontage Labs.: Revenue Share, by Country/Region, FY 2023
Figure 87 : ICON plc: Revenue Share, by Country/Region, FY 2023
Figure 88 : IQVIA Inc: Revenue Share, by Business Unit, FY 2023
Figure 89 : IQVIA Inc: Revenue Share, by Country/Region, FY 2023
Figure 90 : Laboratory Corporation of America Holdings: Revenue Share, by Business Unit, FY 2023
Figure 91 : Laboratory Corporation of America Holdings: Revenue Share, by Country/Region, FY 2023
Figure 92 : Medpace: Revenue Share, by Business Unit, FY 2023
Figure 93 : Medpace: Revenue Share, by Country/Region, FY 2023
Figure 94 : Thermo Fisher Scientific Inc.: Revenue Share, by Business Unit, FY 2023
Figure 95 : Thermo Fisher Scientific Inc.: Revenue Share, by Country/Region, FY 2023
Figure 96 : WuXi AppTec: Revenue Share, by Business Unit, FY 2023
Figure 97 : WuXi AppTec: Revenue Share, by Country/Region, FY 2023